7th Science to Market - "Leveraging Synergies", Frankfurt
2016-03-07 - 2016-03-08
The annual discussion and partnering conference for experts from academia, biotechnology and pharmaceutical industry
In a plenary session the implications of Big Data will be discussed, how they are changing early steps of the discovery landscape and which role they play in drug development. A further session is dealing with the final steps of biopharma development: the regulatory environment. These inspiring plenary sessions will be complemented by the traditional and well-proven format of our tech-transfer sessions. Poster exhibitions will be accompanied by oral presentations. Plenty of room will be given for discussion and personal interactions between scientists from academia, research institutes, and small biotech with pharma companies and investors, thus paving the road from “Science to Market”.
Further information: www.eapb.org/s2m_2015.html